Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopsy
Reports from B. Lieske and co-researchers add new data to research in biopsy
January 29th, 2009
"Screen-detected breast lesions in the National Health Service Breast Screening Programme (NHSBSP) are assessed by core needle biopsy (CB) or fine needle aspiration cytology (FNAC). Most core biopsies are diagnostic and representative, but a small proportion is indeterminate (coded ''B3'' in the NHSBSP)," researchers in Luton, the United Kingdom report. "We studied the surgical outcome of screen-detected breast lesions with indeterminate (B3) CB. We retrieved and analysed the data on women who were recalled for assessment of a screen-detected abnormality in whom the initial CB was reported as B3 over a six-year period from a prospectively collected database in one...
Source: Women's Health Weekly (2009-01-29)
|
